The biotechnology and pharmaceutical industries are important sectors in the global economy, each with its own challenges and opportunities. FGMK can help you meet these challenges and capitalize on promising opportunities.
FGMK’s experience from working with companies in these key market sectors helps us advise them on their complex and unique financial, tax, operational and strategic needs. Our partners and managing directors lead proactive teams of professionals while providing practical business solutions. In addition, our industry-focused approach enables us to identify and respond to key performance and business issues without delay.
FGMK provides services to large and middle-market participants in the biotech and pharmaceuticals industry. We support them through:
Strategic and operational consulting. We perform competitive and benchmarking assessments, review plant efficiencies and identify profit gaps. We design and implement profit improvement plans that address today’s challenges.
Acquisition and divestiture due diligence. We establish criteria for a competitive and strategic business combination transaction, allowing our clients to select and negotiate the best business combination.
Turnaround and restructuring services. We address the necessary changes in cash and liquidity management, debt finance or insolvency to help our clients emerge as viable, competitive participants in the industry.